NSE ScannerComparison · NSE · data 2026-10-31
FDC Ltd. vs Senores Pharmaceuticals Ltd.
In plain words
Size: FDC Ltd. is about 1.2 times the market value of Senores Pharmaceuticals Ltd..
Valuation (P/E): Senores Pharmaceuticals Ltd. 39.2 vs FDC Ltd. 19.6.
Return on equity: Senores Pharmaceuticals Ltd. 13.4% vs FDC Ltd. 11.8%.
Profit growth over 3 years: Senores Pharmaceuticals Ltd. 139.2% a year vs FDC Ltd. 13.2% a year.
Debt to equity: Senores Pharmaceuticals Ltd. 0.37 vs FDC Ltd. 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| FDC | SENORES | |
|---|---|---|
| Price | ₹377 | ₹1,133.9 |
| Market cap | ₹6,132 cr | ₹5,221 cr |
| P/E | 19.6 | 39.2 |
| P/B | 2.3 | 5.2 |
| ROE | 11.8% | 13.4% |
| ROCE | 11.7% | 12.6% |
| Debt / equity | 0.01 | 0.37 |
| Operating margin | 13.9% | 24.3% |
| Dividend yield | 1.33% | 0.00% |
| Sales growth, 3 years (yearly) | 6.8% | 161.6% |
| Profit growth, 3 years (yearly) | 13.2% | 139.2% |
| 1-year return | -14.9% | 46.7% |
| Revenue, last 12 months | ₹2,289 cr | ₹722 cr |
| Net profit, last 12 months | ₹313 cr | ₹133 cr |
| Latest quarter | Dec 2025 | Sept 2026 |
| Quarter net profit | ₹28 cr | ₹39 cr |
| Quarter profit vs a year earlier | -24.5% | +22.0% |
| Promoter holding | 69.66% | 45.82% |
| Health check | Strong (7/10) | Strong (7.3/10) |
Common questions
Which has a higher P/E, FDC Ltd. or Senores Pharmaceuticals Ltd.?
Senores Pharmaceuticals Ltd. trades at the higher P/E (39.2 against 19.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Senores Pharmaceuticals Ltd. (13.4% against 11.8%).
Which carries more debt?
Senores Pharmaceuticals Ltd. has the higher debt-to-equity ratio (0.37 against 0.01).